Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Stewart

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.
Haematologica|November 11, 2003
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantationJohannes Schetelig, Sebastian Fetscher, Albrecht Reichle, et al.
Cell Host & Microbe|March 25, 2015
Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes via conserved epitopesMarcel Wüthrich, Tristan T Brandhorst, Thomas D Sullivan, et al.
F1000Research|May 17, 2018
Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / <i>DICER1</i> syndrome: a unique variant of the two-hit tumor suppression modelMark Brenneman, Amanda Field, Jiandong Yang, et al.
Blood Advances|March 10, 2019
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical modelChandini M Thirukkumaran, Zhong Qiao Shi, Gerard J Nuovo, et al.
Blood|January 9, 2019
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCLMagdalena Klanova, Laurie H Sehn, Isabelle Bence-Bruckler, et al.
Journal of Neuro-Oncology|December 23, 2003
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendrogliomaLauren E Abrey, Barrett H Childs, Nina Paleologos, et al.
Neuro-Oncology|March 10, 2006
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-upLauren E Abrey, Barrett H Childs, Nina Paleologos, et al.
Nature Communications|November 5, 2025
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphomaSunandini Sharma, Roshia Ali, Alyssa Bouska, et al.
Haematologica|April 1, 2021
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphomaMan Chun John Ma, Saber Tadros, Alyssa Bouska, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.
Haematologica|November 11, 2003
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantationJohannes Schetelig, Sebastian Fetscher, Albrecht Reichle, et al.
Cell Host & Microbe|March 25, 2015
Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes via conserved epitopesMarcel Wüthrich, Tristan T Brandhorst, Thomas D Sullivan, et al.
F1000Research|May 17, 2018
Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / <i>DICER1</i> syndrome: a unique variant of the two-hit tumor suppression modelMark Brenneman, Amanda Field, Jiandong Yang, et al.
Blood Advances|March 10, 2019
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical modelChandini M Thirukkumaran, Zhong Qiao Shi, Gerard J Nuovo, et al.
Blood|January 9, 2019
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCLMagdalena Klanova, Laurie H Sehn, Isabelle Bence-Bruckler, et al.
Journal of Neuro-Oncology|December 23, 2003
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendrogliomaLauren E Abrey, Barrett H Childs, Nina Paleologos, et al.
Neuro-Oncology|March 10, 2006
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-upLauren E Abrey, Barrett H Childs, Nina Paleologos, et al.
Nature Communications|November 5, 2025
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphomaSunandini Sharma, Roshia Ali, Alyssa Bouska, et al.
Haematologica|April 1, 2021
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphomaMan Chun John Ma, Saber Tadros, Alyssa Bouska, et al.
Pageof 8